↓ Skip to main content

Role of salvage lymph node dissection in patients previously treated for prostate cancer: systematic review

Overview of attention for article published in International Brazilian Journal of Urology, June 2021
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
19 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Role of salvage lymph node dissection in patients previously treated for prostate cancer: systematic review
Published in
International Brazilian Journal of Urology, June 2021
DOI 10.1590/s1677-5538.ibju.2020.0051
Pubmed ID
Authors

João Paulo Pretti Fantin, Maria Claudia Bicudo Furst, Marcos Tobias-Machado, Roberto Lodeiro Muller, Roberto Dias Machado, Alexandre Cesar Santos, Wesley Justino Magnabosco, Cinthia Alcantara-Quispe, Eliney Ferreira Faria

Abstract

Prostate cancer is the most common invasive cancer in men. Radical prostatectomy (RP) is a definitive treatment option, but biochemical recurrence can reach 40%. Salvage lymphadenectomy is a relatively recent approach to oligometasis and has been rapidly diffused primarily due to improvement in imaging diagnosis and results showing possibly promising therapy. A systematic literature review was performed in March 2020, according to the PRISMA statement. We excluded studies with patients with suspicion or confirmation of visceral and / or bone metastases. A total of 27 articles were included in the study. All studies evaluated were single arm, and there were no randomized studies in the literature. A total of 1,714 patients received salvage lymphadenectomy after previous treatment for localized prostate cancer. RP was the most used initial therapeutic approach, and relapses were based on PET / CT diagnosis, with Coline-11C being the most widely used radiopharmaceutical. Biochemical response rates ranged from 0% to 80%. The 5 years - Free Survival Biochemical recurrence was analyzed in 16 studies with rates of 0% up to 56.1%. The articles do not present high levels of evidence to draw strong conclusions. However, even if significant rates of biochemical recurrence are not evident in all studies, therapy directed to lymph node metastases may present good oncological results and postpone the onset of systemic therapy. The long-term impact in overall survival and quality of life, as well as the best strategies for case selection remains to be determined.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 19 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 19 100%

Demographic breakdown

Readers by professional status Count As %
Student > Doctoral Student 3 16%
Student > Postgraduate 2 11%
Researcher 2 11%
Lecturer 1 5%
Student > Master 1 5%
Other 0 0%
Unknown 10 53%
Readers by discipline Count As %
Medicine and Dentistry 5 26%
Veterinary Science and Veterinary Medicine 1 5%
Economics, Econometrics and Finance 1 5%
Nursing and Health Professions 1 5%
Unknown 11 58%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 November 2020.
All research outputs
#22,771,990
of 25,387,668 outputs
Outputs from International Brazilian Journal of Urology
#624
of 726 outputs
Outputs of similar age
#394,518
of 459,788 outputs
Outputs of similar age from International Brazilian Journal of Urology
#7
of 10 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 726 research outputs from this source. They receive a mean Attention Score of 4.1. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 459,788 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 10 others from the same source and published within six weeks on either side of this one. This one has scored higher than 3 of them.